- $30.35m
- $32.17m
- $5.64m
- 18
- 14
- 46
- 15
Annual balance sheet for Evogene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 46.9 | 48.2 | 53.9 | 35.4 | 31.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.15 | 3.59 | 2.93 | 1.83 | 3.33 |
| Total Inventory | |||||
| Total Current Assets | 49 | 51.8 | 56.9 | 37.8 | 34.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.25 | 3.94 | 4.18 | 4.07 | 3.44 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 71.4 | 71.9 | 76.3 | 56.1 | 51.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.75 | 9.68 | 6.88 | 5.63 | 6.94 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.2 | 25.9 | 22.7 | 28.2 | 39 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 50.1 | 46 | 53.7 | 27.9 | 12.1 |
| Total Liabilities & Shareholders' Equity | 71.4 | 71.9 | 76.3 | 56.1 | 51.1 |
| Total Common Shares Outstanding |